What does Horizon Therapeutics Plc do?

Jun 22 2025 06:23 PM IST
share
Share Via
Horizon Therapeutics Plc is a biopharmaceutical company specializing in medicines for rare and rheumatic diseases, with a market cap of approximately USD 26.54 billion. As of June 2023, it reported net sales of USD 945 million and a net profit of USD 127 million.
Overview:
Horizon Therapeutics Plc is a rare disease biopharmaceutical company focused on researching, developing, and commercializing medicines for rare and rheumatic diseases, operating within the Pharmaceuticals industry and holding a market cap of USD 26,536.85 Million.

Financial Snapshot:
Most recent Net Sales: 945 Million (Quarterly Results - Jun 2023)
Most recent Net Profit: 127 Million (Quarterly Results - Jun 2023)
Market cap: USD 26,536.85 Million

Key Metrics:
P/E: 58.00
Dividend Yield: 0.00%
Debt Equity: 0.01
Return on Equity: 8.57%
Price to Book: 5.00

Contact Details:
Address: Connaught House, 1St Floor, 1 Burlington Road DUBLIN None : D04 C5Y6
Tel: 353 1 7722100
Website: https://www.horizontherapeutics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Horizon Therapeutics Plc overvalued or undervalued?
Jun 25 2025 08:38 AM IST
share
Share Via
Is Horizon Therapeutics Plc technically bullish or bearish?
Jun 25 2025 08:33 AM IST
share
Share Via
Who are in the management team of Horizon Therapeutics Plc?
Jun 22 2025 10:18 PM IST
share
Share Via